A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 6 I, 1998, Pages 1497-1502

  Kjellberg, L ^a   Wiklund, F ^a   Sjoberg, I ^a   Wadell, G ^a   Angstrom, T ^a   Dillner, J ^a   Mahlck, C G ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical intraepithelial neoplasia; Cervical screening chain reaction; Human papillomavirus

Indexed keywords

ADULT; CANCER SCREENING; CONFERENCE PAPER; DISEASE ASSOCIATION; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

EID: 0032441257     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70015-8     Document Type: Conference Paper

References (25)

1. LA Koutsky KK Holmes CW Critchlow CE Stevens J Paavonen AM Beckmann A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 1992 1272 1278
2. J Cuzick G Terry L Ho T Hollingworth M Anderson Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia Br J Cancer 69 1994 167 171
3. SK Kjaer AJ van den Brule JE Bock PA Poll G Engholm ME Sherman Human papillomavirus: the most significant risk determinant of cervical intraepithelial neoplasia Int J Cancer 65 1996 601 606
4. AT Lorincz R Reid AB Jenson MD Greenberg W Lancaster RJ Kurman Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types Obstet Gynecol 79 1992 318 327
5. H zur Hausen E-M de Villiers Human papillomavirus Annu Rev Microbiol 48 1994 427 447
6. J Cuzick G Terry L Ho A Hanby P Maddox M Anderson Human papillomavirus testing in primary cervical screening Lancet 345 1995 1533 1536
7. FX Bosch MM Manos N Munoz M Sherman AM Jansen J Peto Prevalence of human papillomavirus in cervical cancer: a worldwide perspective J Natl Cancer Inst 87 1995 796 802
8. EAB Morrison GYF Ho SH Vermund GL Goldberg AS Kadish KF Kelley Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study Int J Cancer 49 1991 6 13
9. L Rozendaal JMM Walboomers JC van der Linden FJ Voorhorst P Kenemans TJM Helmerhorst PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears Int J Cancer 68 1996 766 769
10. K Chua F Wiklund P Lenner T Ångström G Hallmans F Bergman A prospective cohort study on the risk to develop cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV, in comparison with presence of HPV DNA in cervical smears Int J Cancer 68 1996 54 59
11. KL Chua A Hjerpe Persistence of human papillomavirus infections preceding cervical carcinoma Cancer 77 1996 121 127
12. MH Schiffman Epidemiology of cervical human papillomavirus infections Curr Top Microbiol Immunol 186 1994 55 81
13. CJLM Meijer AJC van den Brule PJF Snijders T Helmerhorst P Kenemans JMM Walboomers Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening IARC Monogr Eval Carcinog Risks Hum 119 1992 271 281
14. M van Ballegooijen ME van Marle PG Warmerdam CJLM Meijer JMM Walboomers JDF Habbema Present evidence on the value of HPV-testing for cervical cancer screening: a model-based exploration of (cost)-effectiveness Br J Cancer 76 1997 651 657
15. JT Cox AT Lorincz MH Schiffman ME Sherman A Cullen RJ Kurman Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance Am J Obstet Gynecol 172 1995 946 954
16. JT Cox HPV DNA testing: clinical boon or boondoggle? Lancet 346 1995 717 718
17. D Jenkins C Sherlaw-Johnson S Gallivan Can papillomavirus testing be used to improve cervical cancer screening? Int J Cancer 65 1996 768 773
18. M Evander K Edlund E Boden Å Gustavsson M Jonsson R Karlsson Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women J Clin Microbiol 30 1992 987 992
19. R Karlsson M Jonsson K Edlund M Evander A Gustavsson E Boden Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study Sex Transm Dis 22 1995 119 127
20. M Evander G Wadell A general primer for amplification and detection of genital human papillomavirus types J Virol Methods 31 1991 239 250
21. MM Manos Y Ting DK Wright AJ Lewis TR Broker SM Wollinsky Use of polymerase chain reaction amplification for the detection of genital human papillomavirus Cancer Cells 7 1989 209 214
22. PJF Snijders AJF van den Brule HJF Schrijnemakers G Snow CJLM Meijer JMM Walboomers The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes J Gen Virol 71 1990 173 181
23. HM Bauer Y Ting CE Greer JC Chambers CJ Tashiro J Chimera Genital human papillomavirus infection in female university students as determined by a PCR-based method JAMA 265 1991 472 478
24. M Hakama AB Miller NE Day Screening for cancer of the uterine cervix 1986 International Agency for Research on Cancer Lyon, France
25. CG Mählck H Jonsson P Lenner Pap smear screening and changes in cervical cancer mortality in Sweden Int J Gynaecol Obstet 44 1994 267 271